Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Patents & EXCLUSIVITIES
Health Canada Patents
Patent Expiration Date : 2012-03-18
Date Granted : 2001-02-06
Brand Name : REMICADE
Patent Number : 2106299
Filing Date : 1992-03-18
Strength per Unit : 100mg / vial
Dosage Form : Lyophilized Powder for Injection
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2012-03-18
Date Granted : 2001-02-06
Patent Expiration Date : 2012-03-18
Date Granted : 2011-06-14
Brand Name : REMICADE
Patent Number : 2324853
Filing Date : 1992-03-18
Strength per Unit : 100mg / vial
Dosage Form : Lyophilized Powder for Injection
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2012-03-18
Date Granted : 2011-06-14
Patent Expiration Date : 2017-08-01
Date Granted : 2012-12-04
Brand Name : REMICADE
Patent Number : 2261630
Filing Date : 1992-03-18
Strength per Unit : 100mg / vial
Dosage Form : Lyophilized Powder for Injection
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2017-08-01
Date Granted : 2012-12-04
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2037-06-28
Date Granted : 2024-01-02
Brand Name : REMSIMA SC
Patent Number : 3028238
Filing Date : 2017-06-28
Strength per Unit : 120 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2037-06-28
Date Granted : 2024-01-02
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2037-06-28
Date Granted : 2024-01-02
Brand Name : REMSIMA SC
Patent Number : 3028238
Filing Date : 2017-06-28
Strength per Unit : 120 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2037-06-28
Date Granted : 2024-01-02
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
